CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.
about
The rise and fall of tuberculosis in Malawi: associations with HIV infection and antiretroviral therapy.Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB TestScale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis.Mycobacterium tuberculosis: 2014 Clinical trials in reviewCD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis.Care continuum entry interventions: seek and test strategies to engage persons most impacted by HIV within the United States.
P2860
CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
CD4 deficit and tuberculosis r ...... 5-year data from CIPRA HT-001.
@ast
CD4 deficit and tuberculosis r ...... 5-year data from CIPRA HT-001.
@en
type
label
CD4 deficit and tuberculosis r ...... 5-year data from CIPRA HT-001.
@ast
CD4 deficit and tuberculosis r ...... 5-year data from CIPRA HT-001.
@en
prefLabel
CD4 deficit and tuberculosis r ...... 5-year data from CIPRA HT-001.
@ast
CD4 deficit and tuberculosis r ...... 5-year data from CIPRA HT-001.
@en
P2093
P356
P1476
CD4 deficit and tuberculosis r ...... 5-year data from CIPRA HT-001
@en
P2093
D W Fitzgerald
M A Jean Juste
O Ocheretina
S E Collins
P356
10.5588/IJTLD.14.0217
P50
P577
2015-01-01T00:00:00Z